130 related articles for article (PubMed ID: 10740249)
1. Wielding more power over angiogenesis.
Habeck M
Mol Med Today; 2000 Apr; 6(4):138-9. PubMed ID: 10740249
[No Abstract] [Full Text] [Related]
2. Tumor suppression through angiogenesis inhibition.
Arsham AM; Simon MC
Methods Mol Biol; 2003; 223():249-70. PubMed ID: 12777736
[No Abstract] [Full Text] [Related]
3. PR39, a peptide regulator of angiogenesis.
Li J; Post M; Volk R; Gao Y; Li M; Metais C; Sato K; Tsai J; Aird W; Rosenberg RD; Hampton TG; Sellke F; Carmeliet P; Simons M
Nat Med; 2000 Jan; 6(1):49-55. PubMed ID: 10613823
[TBL] [Abstract][Full Text] [Related]
4. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
Knowles HJ; Tian YM; Mole DR; Harris AL
Circ Res; 2004 Jul; 95(2):162-9. PubMed ID: 15192023
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia and angiogenesis in rheumatoid arthritis.
Taylor PC; Sivakumar B
Curr Opin Rheumatol; 2005 May; 17(3):293-8. PubMed ID: 15838239
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.
Giatromanolaki A; Sivridis E; Maltezos E; Papazoglou D; Simopoulos C; Gatter KC; Harris AL; Koukourakis MI
J Clin Pathol; 2003 Mar; 56(3):209-13. PubMed ID: 12610101
[TBL] [Abstract][Full Text] [Related]
8. A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell lines.
Chong TW; Horwitz LD; Moore JW; Sowter HM; Harris AL
Cancer Res; 2002 Dec; 62(23):6924-7. PubMed ID: 12460908
[TBL] [Abstract][Full Text] [Related]
9. Antitumor efficacy of FK228, a novel histone deacetylase inhibitor, depends on the effect on expression of angiogenesis factors.
Sasakawa Y; Naoe Y; Noto T; Inoue T; Sasakawa T; Matsuo M; Manda T; Mutoh S
Biochem Pharmacol; 2003 Sep; 66(6):897-906. PubMed ID: 12963476
[TBL] [Abstract][Full Text] [Related]
10. UCN-01, a protein kinase C inhibitor, inhibits endothelial cell proliferation and angiogenic hypoxic response.
Kruger EA; Blagosklonny MV; Dixon SC; Figg WD
Invasion Metastasis; 1998-1999; 18(4):209-18. PubMed ID: 10640907
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis, angiogenic factor expression and prognosis of bladder cancer.
Streeter EH; Crew JP
Anticancer Res; 2001; 21(6B):4355-63. PubMed ID: 11908691
[TBL] [Abstract][Full Text] [Related]
12. Regulation of angiogenesis by hypoxia: role of the HIF system.
Pugh CW; Ratcliffe PJ
Nat Med; 2003 Jun; 9(6):677-84. PubMed ID: 12778166
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia up-regulates expression of peroxisome proliferator-activated receptor gamma angiopoietin-related gene (PGAR) in cardiomyocytes: role of hypoxia inducible factor 1alpha.
Belanger AJ; Lu H; Date T; Liu LX; Vincent KA; Akita GY; Cheng SH; Gregory RJ; Jiang C
J Mol Cell Cardiol; 2002 Jul; 34(7):765-74. PubMed ID: 12099716
[TBL] [Abstract][Full Text] [Related]
14. Observation of incipient tumor angiogenesis that is independent of hypoxia and hypoxia inducible factor-1 activation.
Cao Y; Li CY; Moeller BJ; Yu D; Zhao Y; Dreher MR; Shan S; Dewhirst MW
Cancer Res; 2005 Jul; 65(13):5498-505. PubMed ID: 15994919
[TBL] [Abstract][Full Text] [Related]
15. Genistein inhibited retinal neovascularization and expression of vascular endothelial growth factor and hypoxia inducible factor 1alpha in a mouse model of oxygen-induced retinopathy.
Wang B; Zou Y; Li H; Yan H; Pan JS; Yuan ZL
J Ocul Pharmacol Ther; 2005 Apr; 21(2):107-13. PubMed ID: 15857276
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis in ischemic and neoplastic disorders.
Semenza GL
Annu Rev Med; 2003; 54():17-28. PubMed ID: 12359828
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary vascular responses to chronic hypoxia mediated by hypoxia-inducible factor 1.
Semenza GL
Proc Am Thorac Soc; 2005; 2(1):68-70. PubMed ID: 16113471
[TBL] [Abstract][Full Text] [Related]
18. A radicicol derivative, KF58333, inhibits expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor, angiogenesis and growth of human breast cancer xenografts.
Kurebayashi J; Otsuki T; Kurosumi M; Soga S; Akinaga S; Sonoo H
Jpn J Cancer Res; 2001 Dec; 92(12):1342-51. PubMed ID: 11749701
[TBL] [Abstract][Full Text] [Related]
19. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.
Ravi R; Mookerjee B; Bhujwalla ZM; Sutter CH; Artemov D; Zeng Q; Dillehay LE; Madan A; Semenza GL; Bedi A
Genes Dev; 2000 Jan; 14(1):34-44. PubMed ID: 10640274
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha.
Oh SH; Woo JK; Jin Q; Kang HJ; Jeong JW; Kim KW; Hong WK; Lee HY
Int J Cancer; 2008 Jan; 122(1):5-14. PubMed ID: 17764071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
